Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide and polyethylene glycol bowel preparation comparison before colonoscopy
ChiCTR1900028102Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Jan 2020
- Modality
- Small Molecules, Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of linaclotide, simethicone and macrogol (3 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoint: Degree of intestinal cleansing. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
linaclotidesimethiconemacrogol
Beyond the preview
Go deeper on ChiCTR1900028102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028102.